Research Article| Volume 54, ISSUE 2, P263-270, May 1982

A longitudinal study of antibrain antibodies in multiple sclerosis

      This paper is only available as a PDF. To read, Please Download here.


      The presence of complement-fixing antibrain antibodies is a distinctive feature of multiple sclerosis (MS). In a longitudinal study of 35 MS patients antibrain antibody titres in serum were followed for up to 5 years; in 18 of them also CSF titres were determined. No consistent correlations between antibrain antibody titres and clinical events were found. Thus, MS relapses are not caused by a general increase in antibrain antibody titres, and conversely the relapses did not cause a boosting of antibrain antibodies. Significant variations in the local plaque environment are, however, not ruled out by the present results.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Esiri M.
        Multiple sclerosis — A quantitative and qualitative study of immunoglobulin-containing cells in the central nervous system.
        Neuropath. appl. Neurobiol. 1980; 6: 9-21
        • Frick E.
        • Stickl H.
        Antibody-dependent lymphocyte cytotoxicity against basic protein of myelin in multiple sclerosis.
        J. neurol. Sci. 1980; 46: 187-197
        • Mattson D.H.
        • Roos R.P.
        • Arnason B.G.W.
        Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains.
        Nature (Lond.). 1980; 287: 335-337
        • Müller R.
        Studies on disseminated sclerosis.
        Acta med. scand. 1949; 133: 1-214
        • Reinherz E.L.
        • Weiner H.L.
        • Hansen S.L.
        • Cohen J.A.
        • Distaso J.A.
        • Schlossmann S.F.
        Loss of suppressor T cells in active multiple sclerosis.
        N. Engl. J. Med. 1980; 303: 125-129
        • Reunanen M.
        • Arstila P.
        • Hakkarainen H.
        • Nikoskelainen J.
        • Salmi A.
        • Panelius M.
        A longitudinal study on antibodies to measles and rubella viruses in patients with multiple sclerosis — A preliminary report.
        Acta neurol. scand. 1976; 54: 366-370
        • Ryberg B.
        Multiple specificities of antibrain antibodies in multiple sclerosis and chronic myelopathy.
        J. neurol. Sci. 1978; 38: 357-382
        • Ryberg B.
        Intrathecal and extrathecal production of antibrain antibodies in multiple sclerosis.
        J. neurol. Sci. 1980; 48: 1-8
        • Ryberg B.
        Antibrain antibodies in multiple sclerosis — Relation to clinical variables.
        J. neurol. Sci. 1982; 54: 239-261
        • Ryberg B.
        • Kronvall G.
        Immunoglobulin characterization by bacterial absorption of antibrain antibodies in multiple sclerosis.
        Europ. Neurol. 1981; 20: 374-379
        • Sibley W.A.
        • Foley J.M.
        Infection and immunization in multiple sclerosis.
        Ann. N.Y. Acad. Sci. 1965; 122: 457-468